Docusign ( DOCU) shares sank 18% Friday, a day after the electronic signing software maker's billings missed estimates and it ...

The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

Is ENPH stock a worthwhile purchase following such a considerable drop? This steep decrease for Enphase Energy stands out ...

On Friday, RBC Capital analysts maintained their Sector Perform rating and a $90.00 price target for Docusign Inc ... and led to a significant decline in the stock’s after-hours trading.

DocuSign has experienced a notable decline in its stock price, dropping by 15.61% over the past week. This movement comes amidst a series of analyst reports maintaining a ‘Hold ...

On a year-to-date basis, DOCU has gained nearly 4 %, outperforming the broader S&P 500 Index, which rose 1.51% during the ...

Docusign DOCU will report first-quarter ... indicating an 11.4% year-over-year decline. The DOCU stock is looking pricier than BILL Holdings but cheaper than BlackLine and the industry as a ...

which showed mixed results and led to a significant decline in the stock’s after-hours trading. According to InvestingPro data, the stock is currently trading below its Fair Value, despite showing ...

Docusign DOCU will report first-quarter fiscal 2026 results on June 5, after market close. The Zacks Consensus Estimate for ...

DocuSign maintains a strong market position with a robust feature set and high popularity,” said Seeking Alpha analyst Khaveen Investments, rating the stock as Buy. However, Wall Street analysts ...